tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Dyne Therapeutics Highlights Pipeline and Cash at JPM Conference
PremiumCompany AnnouncementsDyne Therapeutics Highlights Pipeline and Cash at JPM Conference
2M ago
Dyne Therapeutics Appoints Vikram Karnani to Board
Premium
Company Announcements
Dyne Therapeutics Appoints Vikram Karnani to Board
2M ago
Dyne Therapeutics appoints Vikram Karnani to board of directors
Premium
The Fly
Dyne Therapeutics appoints Vikram Karnani to board of directors
2M ago
Oppenheimer upgrades Dyne Therapeutics to Outperform, raises target to $40
PremiumThe FlyOppenheimer upgrades Dyne Therapeutics to Outperform, raises target to $40
3M ago
Dyne Therapeutics upgraded to Outperform from Perform at Oppenheimer
Premium
The Fly
Dyne Therapeutics upgraded to Outperform from Perform at Oppenheimer
3M ago
Dyne Therapeutics 18.98M share Secondary priced at $18.44
Premium
The Fly
Dyne Therapeutics 18.98M share Secondary priced at $18.44
3M ago
Dyne Therapeutics price target raised to $23 from $21 at Bernstein
PremiumThe FlyDyne Therapeutics price target raised to $23 from $21 at Bernstein
3M ago
Dyne Therapeutics Amends Loan Agreement for $50 Million
Premium
Company Announcements
Dyne Therapeutics Amends Loan Agreement for $50 Million
3M ago
Dyne Therapeutics offers to sell $300M in common stock
Premium
The Fly
Dyne Therapeutics offers to sell $300M in common stock
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100